Literature DB >> 3183524

Serum lathosterol concentration is an indicator of whole-body cholesterol synthesis in humans.

H J Kempen1, J F Glatz, J A Gevers Leuven, H A van der Voort, M B Katan.   

Abstract

The power of serum lathosterol concentration as an indicator of whole-body cholesterol synthesis was investigated in 47 human volunteers consuming two diets differing in fatty acid composition. The cholesterol balance (fecal excretion of neutral and acid steroids minus cholesterol intake) was strongly correlated with the serum level of total (free plus esterified) lathosterol and also with the ratio of serum lathosterol over serum cholesterol, both on a diet rich in polyunsaturated fatty acids (r = 0.74 for the ratio) and one containing mainly saturated fatty acids (r = 0.70 for the ratio). In a subgroup for which the serum levels of free lanosterol and other free methylsterols were also quantitated, the correlations of these levels (expressed relative to serum free cholesterol) with the cholesterol balance were lower than that found for total lathosterol (expressed relative to serum total cholesterol). A further corroboration was obtained by measuring the lathosterol/cholesterol ratio in 20 patients with familial hypercholesterolemia before and during treatment with the hydroxymethylglutaryl coenzyme A reductase inhibitor Mk-733. The ratio was lowered by 47% during drug treatment, suggesting a significant decrease of the cholesterol balance in these patients. We conclude, from the various indicators proposed to monitor whole-body cholesterol synthesis, that the lathosterol/cholesterol ratio in serum appears preferable with respect to indicative power and ease of quantitation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3183524

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  52 in total

1.  Deuterium uptake and plasma cholesterol precursor levels correspond as methods for measurement of endogenous cholesterol synthesis in hypercholesterolemic women.

Authors:  N R Matthan; M Raeini-Sarjaz; A H Lichtenstein; L M Ausman; P J Jones
Journal:  Lipids       Date:  2000-09       Impact factor: 1.880

2.  Marked variability in hepatic expression of cytochromes CYP7A1 and CYP27A1 as compared to cerebral CYP46A1. Lessons from a dietary study with omega 3 fatty acids in hamsters.

Authors:  Natalia Mast; Marjan Shafaati; Wahiduz Zaman; Wenchao Zheng; Deborah Prusak; Thomas Wood; G A S Ansari; Anita Lövgren-Sandblom; Maria Olin; Ingemar Bjorkhem; Irina Pikuleva
Journal:  Biochim Biophys Acta       Date:  2010-03-16

3.  Understanding the cholesterol metabolism-perturbing effects of docosahexaenoic acid by gas chromatography-mass spectrometry targeted metabonomic profiling.

Authors:  Priti Bahety; Thi Hai Van Nguyen; Yanjun Hong; Luqi Zhang; Eric Chun Yong Chan; Pui Lai Rachel Ee
Journal:  Eur J Nutr       Date:  2015-10-01       Impact factor: 5.614

4.  Inhibition of cholesterol absorption by HMG-CoA reductase inhibitor.

Authors:  T A Miettinen
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

5.  Evaluation of cholesterol metabolism in cerebrotendinous xanthomatosis.

Authors:  Andrea Mignarri; Alessandro Magni; Marina Del Puppo; Gian Nicola Gallus; Ingemar Björkhem; Antonio Federico; Maria Teresa Dotti
Journal:  J Inherit Metab Dis       Date:  2015-07-08       Impact factor: 4.982

Review 6.  Influence of drug transporter polymorphisms on pravastatin pharmacokinetics in humans.

Authors:  Kari T Kivistö; Mikko Niemi
Journal:  Pharm Res       Date:  2006-12-20       Impact factor: 4.200

7.  Baseline serum cholestanol as predictor of recurrent coronary events in subgroup of Scandinavian simvastatin survival study. Finnish 4S Investigators.

Authors:  T A Miettinen; H Gylling; T Strandberg; S Sarna
Journal:  BMJ       Date:  1998-04-11

8.  The combination of ezetimibe and ursodiol promotes fecal sterol excretion and reveals a G5G8-independent pathway for cholesterol elimination.

Authors:  Yuhuan Wang; Xiaoxi Liu; Sonja S Pijut; Jianing Li; Jamie Horn; Emily M Bradford; Markos Leggas; Terrence A Barrett; Gregory A Graf
Journal:  J Lipid Res       Date:  2015-01-29       Impact factor: 5.922

9.  Lack of effect of lovastatin therapy on the parameters of whole-body cholesterol metabolism.

Authors:  I J Goldberg; S Holleran; R Ramakrishnan; M Adams; R H Palmer; R B Dell; D S Goodman
Journal:  J Clin Invest       Date:  1990-09       Impact factor: 14.808

10.  Determination of key intermediates in cholesterol and bile acid biosynthesis by stable isotope dilution mass spectrometry.

Authors:  Tadashi Yoshida; Akira Honda; Hiroshi Miyazaki; Yasushi Matsuzaki
Journal:  Anal Chem Insights       Date:  2008-03-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.